Literature DB >> 3914413

Hypokalemic myopathy associated with primary aldosteronism and glycyrrhizine-induced pseudoaldosteronism.

S Ishikawa, T Saito, K Okada, T Atsumi, T Kuzuya.   

Abstract

Enzymatic and histological features of muscular disorders associated with primary aldosteronism and glycyrrhizine-induced pseudoaldosteronism were studied. Among 10 patients with primary aldosteronism and 3 patients with pseudoaldosteronism, 5 patients were admitted to our hospital because of muscular weakness. The serum potassium (K) level was 1.86 +/- 0.21 mEq/l in a myopathy group on admission, a value significantly less than that of the 2.74 +/- 0.10 mEq/l in a non-myopathy group (p less than 0.01). Serum creatine phosphokinase (CPK), glutamate-oxyloacetate transaminase (GOT), and lactate dehydrogenase (LDH) were increased in the myopathy group compared to the non-myopathy group; serum CPK was 1412.6 +/- 902.6 vs. 22.8 +/- 5.0 mU/ml, serum GOT was 186.4 +/- 75.3 vs. 24.2 +/- 5.4 mU/ml (p less than 0.05), and serum LDH was 1133.4 +/- 377.3 vs. 387.6 +/- 42.5 mU/ml (p less than 0.05) in the groups with and without myopathy. Analysis of CPK isozymes revealed that the MM type exceeded 95%. The elevated serum CPK, GOT and LDH rapidly decreased to the normal range and muscular strength completely improved within 6 to 13 days after hospitalization, when the serum K level remained below than normal. Light microscopic finding of damaged muscle showed the diffuse necrosis and vacuolization of muscle fibers. Electron microscopic study clearly demonstrated complete dissolution of myofilaments with disappearance of sarcoplasmic reticulum and T-tubules in the necrotic muscle fibers. These results indicate that muscular lesions may occur in primary aldosteronism and pseudoaldosteronism when the serum K level is decreased to below 2.0 mEq/l. This myopathy is not periodic paralysis but hypokalemic myopathy. The mechanism by which K deficiency causes muscular damage remains unknown.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3914413     DOI: 10.1507/endocrj1954.32.793

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  3 in total

1.  Conn's syndrome (primary hyperaldosteronism) simulating polymyositis.

Authors:  Timuçin Kaşifoğlu; Cengiz Korkmaz; Ozgül Paşaoğlu
Journal:  Rheumatol Int       Date:  2004-03-18       Impact factor: 2.631

2.  Adverse Events Associated with Ethical Kampo Formulations: Analysis of the Domestic Adverse-Event Data Reports of the Ministry of Health, Labor, and Welfare in Japan.

Authors:  Yutaka Shimada; Makoto Fujimoto; Tatsuya Nogami; Hidetoshi Watari
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-15       Impact factor: 2.629

3.  Celiac Disease Complicated by Rhabdomyolysis.

Authors:  Mia Fujisawa; Masashi Matsushima; Takashi Ueda; Motoki Kaneko; Ryutaro Fujimoto; Masaya Sano; Erika Teramura; Makiko Monma; Hajime Mizukami; Fumio Nakahara; Hidekazu Suzuki; Takayoshi Suzuki
Journal:  Intern Med       Date:  2020-09-12       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.